Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    ARV-471

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Benefit
    Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Benefit

    11 Dec 2024

    // PRESS RELEASE

    https://www.pfizer.com/news/press-release/press-release-detail/arvinas-and-pfizer-announce-initial-phase-1b-data-tactive-u

    PRESS RELEASE
    11 Dec 2024
    Share Share
    Arvinas's Vepdegestrant Posters at 2024 San Antonio Symposium
    Arvinas's Vepdegestrant Posters at 2024 San Antonio Symposium

    25 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/25/2987123/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-San-Antonio-Breast-Cancer-Symposium.html

    GLOBENEWSWIRE
    25 Nov 2024
    Share Share
    Arvinas & Pfizer announce updated clinical data from Ph1b Trial of Vepdegestrant
    Arvinas & Pfizer announce updated clinical data from Ph1b Trial of Vepdegestrant

    18 May 2024

    // INDINPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/arvinas-and-pfizer-announce-updated-clinical-data-from-phase-1b-trial-of-vepdegestrant-in-combination-with-palbociclib-15660

    INDINPHARMAPOST
    18 May 2024
    Share Share
    Arvinas, Pfizer Update Vepdegestrant + Palbociclib Phase 1b Data
    Arvinas, Pfizer Update Vepdegestrant + Palbociclib Phase 1b Data

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883219/0/en/Arvinas-and-Pfizer-Announce-Updated-Clinical-Data-from-Phase-1b-Trial-of-Vepdegestrant-in-Combination-with-Palbociclib-IBRANCE.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    Arvinas Vepdegestrant Posters At ESMO Breast Cancer Congress 2024
    Arvinas Vepdegestrant Posters At ESMO Breast Cancer Congress 2024

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2879260/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-European-Society-for-Medical-Oncology-ESMO-Breast-Cancer-Annual-Congress.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib
    Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib

    14 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share